Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

Data as of Oct 22
 -0.10 / -6.85%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Navidea Biopharmaceuticals, Inc. develops and commercializes precision diagnostics and radiopharmaceutical agents, which are intended to improve diagnostic accuracy, clinical decision-making and patient care. Its current radiopharmaceutical development programs include Lymphoseek, AZD4694 and RIGScan agents, which are used in treating various tumor cancers. The company's primary focus in to improve surgery outcomes by using market-leading gamma detection devices in combination with radiopharmaceutical agents. The company was founded in 1983 and is headquartered in Dublin, OH.

Contact Information

Navidea Biopharmaceuticals, Inc.
425 Metro Place North
Dublin Ohio 43017-1367
P:(614) 793-7500
Investor Relations:
(614) 822-2330



Mutual fund holders7.72%
Other institutional29.51%
Individual stakeholders11.14%

Top Executives

Rick GonzalezChief Executive Officer
Thomas H. TulipPresident & Chief Business Officer
Brent L. LarsonCFO, Secretary, Treasurer & Executive VP
Frederick O. CopeChief Scientific Officer & Senior Vice President
Cornelia B. ReiningerChief Medical Officer & Senior Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.